IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Teva Buys U.S. Generic Drugmaker

10:24 AM MDT | August 4, 2008 | Deepti Ramesh

Teva Pharmaceutical Industries Ltd. (Petach Tikva, Israel) says it has completed the acquisition of Bentley Pharmaceuticals (Exeter, NH) for about $360 million. Bentley produces generic pharmaceuticals, which generated revenues of about $114 million in 2007. Teva expects the acquisition to become accretive to earnings within 12 months. Bentley spun off a drug delivery business to shareholders in June and currently manufactures and markets about 130 pharma products, as well as active pharmaceutical ingredients (APIs) through its subsidiary Bentley API. The...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa